Ellen O'Connor Vos, Director at OptimizeRx Corp (OPRX), bought 500 shares at $15.91 ($8K) on 2022-08-16, disclosed to the SEC on 2022-08-17.
Open-market purchase of $8k OPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| OPRX | BUY | 2020-04-01 | $9K | — | Filing → |
| OPRX | BUY | 2019-11-14 | $6K | — | Filing → |
| OPRX | BUY | 2018-06-27 | $19K | — | Filing → |